A detailed history of Mercer Global Advisors Inc transactions in Cybin Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 29,000 shares of CYBN stock, worth $288,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,000
Previous 29,000 -0.0%
Holding current value
$288,260
Previous $12,000 41.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.3 - $0.46 $1,800 - $2,760
6,000 Added 26.09%
29,000 $12,000
Q3 2023

Nov 13, 2023

BUY
$0.29 - $0.63 $6,669 - $14,490
23,000 New
23,000 $12,000
Q1 2022

May 10, 2022

SELL
$0.74 - $1.22 $370 - $610
-500 Reduced 4.0%
12,000 $10,000
Q4 2021

Feb 04, 2022

BUY
$1.13 - $2.31 $14,124 - $28,875
12,500 New
12,500 $15,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.65B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.